Optimum Clinical Research Group- Women's Oncology — Albuquerque, New Mexico

Optimum Clinical Research Group- Women's Oncology is a clinical research site located in Albuquerque, New Mexico, United States 87109.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Optimum Clinical Research Group- Women's Oncology has participated in 2 clinical trials.

Therapeutic areas: Ovarian Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Carcinoma.

Sponsors: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Albuquerque

Browse all research sites in New Mexico · View every site in Albuquerque

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Optimum Clinical Research Group- Women's Oncology?

Optimum Clinical Research Group- Women's Oncology has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Optimum Clinical Research Group- Women's Oncology conducted?

Optimum Clinical Research Group- Women's Oncology has 2 clinical trials on record. Their work covers Ovarian Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Carcinoma.

Is Optimum Clinical Research Group- Women's Oncology accredited by Crixeo Clinical Trials?

Optimum Clinical Research Group- Women's Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Optimum Clinical Research Group- Women's Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.